Continuum Advisory, LLC Biomarin Pharmaceutical Inc Transaction History
Continuum Advisory, LLC
- $727 Million
- Q1 2025
A detailed history of Continuum Advisory, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Continuum Advisory, LLC holds 11 shares of BMRN stock, worth $667. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 17
35.29%
Holding current value
$667
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
667Shares Held
186MCall Options Held
1.25MPut Options Held
992K-
Black Rock Inc. New York, NY22.7MShares$1.38 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.15 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.08 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$907 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$655 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...